|
1
|
Gosain R, Mukherjee S, Yendamuri SS and
Iyer R: Management of typical and atypical pulmonary carcinoids
based on different established guidelines. Cancers (Basel).
10(510)2018.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Rosado de Christenson ML, Abbott GF,
Kirejczyk WM, Galvin JR and Travis WD: Thoracic carcinoids:
Radiologic-pathologic correlation. Radiographics. 19:707–736.
1999.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Hemminki K and Li X: Incidence trends and
risk factors of carcinoid tumors: A nationwide epidemiologic study
from Sweden. Cancer. 92:2204–2210. 2001.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Quaedvlieg PF, Visser O, Lamers CB,
Janssen-Heijen ML and Taal BG: Epidemiology and survival in
patients with carcinoid disease in The Netherlands. An
epidemiological study with 2391 patients. Ann Oncol. 12:1295–1300.
2001.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Rekhtman N: Neuroendocrine tumors of the
lung: An update. Arch Pathol Lab Med. 134:1628–1638.
2010.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Zeng Y, Zhu Y, Ding Y, Xu L, Zhai B, Zhang
X, Ge Q, Li J, Song Q, Li X and Zhang Z: Analysis of lung biopsies
using the 2015 WHO criteria and detection of sensitizing
mutations-a single-institution experience of 5032 cases. Diagn
Pathol. 15(59)2020.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Mjønes P, Sagatun L, Nordrum IS and Waldum
HL: Neuron-specific enolase as an immunohistochemical marker is
better than its reputation. J Histochem Cytochem. 65:687–703.
2017.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Gledhill A, Sparham C and Dixon MF:
Expression of epithelial membrane antigen by carcinoid tumours. J
Clin Pathol. 43:696–697. 1990.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Bishopric GA Jr and Ordóñez NG:
Carcinoembryonic antigen in primary carcinoid tumors of the lung.
Cancer. 58:1316–1320. 1986.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Huang Y, Yang X, Lu T, Li M, Zhao M, Yang
X, Ma K, Wang S, Zhan C, Liu Y and Wang Q: Assessment of the
prognostic factors in patients with pulmonary carcinoid tumor: A
population-based study. Cancer Med. 7:2434–2441. 2018.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Georgakopoulou VE, Zygouris E, Nikokiris
C, Damaskos C, Pierrakou A, Garmpis N, Garmpi A, Sklapani P,
Aravantinou A, Trakas N, et al: Predictive indicators of survival
in patients with surgically resected lung carcinoid tumors at a
Greek medical center. Cureus. 12(e10300)2020.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Graziano SL, Tatum AH, Newman NB, Oler A,
Kohman LJ, Veit LJ, Gamble GP, Coleman MJ, Barmada S and O'Lear S:
The prognostic significance of neuroendocrine markers and
carcinoembryonic antigen in patients with resected stage I and II
non-small cell lung cancer. Cancer Res. 54:2908–2913.
1994.PubMed/NCBI
|
|
13
|
Yaman B, Nart D, Ekren PK, Çok G and Veral
A: Expression of p63, TTF-1 and maspin in non-small cell lung
carcinoma and their effect on the prognosis and differential
diagnosis. Turk Patoloji Derg. 31:163–174. 2015.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Ather MH, Abbas F, Faruqui N, Israr M and
Pervez S: Correlation of three immunohistochemically detected
markers of neuroendocrine differentiation with clinical predictors
of disease progression in prostate cancer. BMC Urol.
8(21)2008.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Tudoraşcu DR, Pirici D, Târtea EA, Mustafa
ER, Florescu C, Vere CC, Balea AM, Puiu I, Târtea GC and Albu VC:
Synaptophysin expression as prognostic factor for survival in
colorectal carcinomas. Rom J Morphol Embryol. 58:1409–1415.
2017.PubMed/NCBI
|
|
16
|
Wang L, Wang Z, Xia ZJ, Lu Y, Huang HQ and
Zhang YJ: CD56-negative extranodal NK/T cell lymphoma should be
regarded as a distinct subtype with poor prognosis. Tumour Biol.
36:7717–7723. 2015.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Bamias A, Chorti M, Deliveliotis C, Trakas
N, Skolarikos A, Protogerou B, Legaki S, Tsakalou G, Tamvakis N and
Dimopoulos MA: Prognostic significance of CA 125, CD44, and
epithelial membrane antigen in renal cell carcinoma. Urology.
62:368–373. 2003.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Travis WD, Brambilla E, Nicholson AG,
Yatabe Y, Austin JHM, Beasley MB, Chirieac LR, Dacic S, Duhig E,
Flieder DB, et al: The 2015 World Health Organization
classification of lung tumors: Impact of genetic, clinical and
radiologic advances since the 2004 classification. J Thorac Oncol.
10:1243–1260. 2015.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Feng SH and Yang ST: The new 8th TNM
staging system of lung cancer and its potential imaging
interpretation pitfalls and limitations with CT image
demonstrations. Diagn Interv Radiol. 25:270–279. 2019.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Vesterinen T, Mononen S, Salmenkivi K,
Mustonen H, Räsänen J, Salo JA, Ilonen I, Knuuttila A, Haglund C
and Arola J: Clinicopathological indicators of survival among
patients with pulmonary carcinoid tumor. Acta Oncol. 57:1109–1116.
2018.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Ramirez RA, Beyer DT, Diebold AE, Voros
BA, Chester MM, Wang YZ, Boudreaux JP, Woltering EA, Uhlhorn AP,
Ryan P, et al: Prognostic factors in typical and atypical pulmonary
carcinoids. Ochsner J. 17:335–340. 2017.PubMed/NCBI
|
|
22
|
Filosso PL, Ruffini E, Di Gangi S,
Guerrera F, Bora G, Ciccone G, Galassi C, Solidoro P, Lyberis P,
Oliaro A and Sandri A: Prognostic factors in neuroendocrine tumours
of the lung: A single-centre experience. Eur J Cardiothorac Surg.
45:521–526. 2014.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Wang J, Ma Y, Zhu ZH, Situ DR, Hu Y and
Rong TH: Expression and prognostic relevance of tumor
carcinoembryonic antigen in stage IB non-small cell lung cancer. J
Thorac Dis. 4:490–496. 2012.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Ianniello A, Sansovini M, Severi S,
Nicolini S, Grana CM, Massri K, Bongiovanni A, Antonuzzo L, Di
Iorio V, Sarnelli A, et al: Peptide receptor radionuclide therapy
with (177)Lu-DOTATATE in advanced bronchial carcinoids: Prognostic
role of thyroid transcription factor 1 and (18)F-FDG PET. Eur J
Nucl Med Mol Imaging. 43:1040–1046. 2016.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Wang X, Zhang Y, Hu M, Wang R, Liu L, Qian
K, Li Y and Zhi X: Prognostic and predictive value of thyroid
transcription factor-1, CD56, P40 and other clinical
characteristics in small cell lung cancer patients. Zhongguo Fei Ai
Za Zhi. 20:522–527. 2017.PubMed/NCBI View Article : Google Scholar : (In Chinese).
|
|
26
|
Feng J, Sheng H, Zhu C, Qian X, Wan D, Su
D, Chen X and Zhu L: Correlation of neuroendocrine features with
prognosis of non-small cell lung cancer. Oncotarget. 7:71727–71736.
2016.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Touhami H, Sotto JJ, Sotto MF, Couderc P,
Keddari E, Brahimi S and Kubisz P: Prognostic value of the
epithelial membrane antigen (EMA) in the case of Hodgkin's disease.
Neoplasma. 38:433–437. 1991.PubMed/NCBI
|
|
28
|
Kim GJ, Rhee H, Yoo JE, Ko JE, Lee JS, Kim
H, Choi JS and Park YN: Increased expression of CCN2, epithelial
membrane antigen, and fibroblast activation protein in
hepatocellular carcinoma with fibrous stroma showing aggressive
behavior. PLoS One. 9(e105094)2014.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Jørgensen LG, Osterlind K, Genollá J, Gomm
SA, Hernández JR, Johnson PW, Løber J, Splinter TA and Szturmowicz
M: Serum neuron-specific enolase (S-NSE) and the prognosis in
small-cell lung cancer (SCLC): A combined multivariable analysis on
data from nine centres. Br J Cancer. 74:463–467. 1996.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Barlési F, Gimenez C, Torre JP, Doddoli C,
Mancini J, Greillier L, Roux F and Kleisbauer JP: Prognostic value
of combination of Cyfra 21-1, CEA and NSE in patients with advanced
non-small cell lung cancer. Respir Med. 98:357–362. 2004.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Jiang R, Wang X and Li K: Predictive and
prognostic value of preoperative serum tumor markers is EGFR
mutation-specific in resectable non-small-cell lung cancer.
Oncotarget. 7:26823–26836. 2016.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Petrovic M, Tomic I, Plavec G, Ilic S,
Ilic N and Baskic D: Neuron specific enolase tissue expression as a
prognostic factor in advanced non small cell lung cancer. J BUON.
13:93–96. 2008.PubMed/NCBI
|
|
33
|
Tiseo M, Ardizzoni A, Cafferata MA,
Loprevite M, Chiaramondia M, Filiberti R, Marroni P, Grossi F and
Paganuzzi M: Predictive and prognostic significance of
neuron-specific enolase (NSE) in non-small cell lung cancer.
Anticancer Res. 28:507–513. 2008.PubMed/NCBI
|
